This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brachmann, S. M.
Right arrow Articles by Cantley, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brachmann, S. M.
Right arrow Articles by Cantley, L. C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2005, p. 2593-2606, Vol. 25, No. 7
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.7.2593-2606.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Role of Phosphoinositide 3-Kinase Regulatory Isoforms in Development and Actin Rearrangement

Saskia M. Brachmann,1,2 Claudine M. Yballe,1 Metello Innocenti,3 Jonathan A. Deane,4 David A. Fruman,4 Sheila M. Thomas,5 and Lewis C. Cantley1*

Division of Signal Transduction, Department of Systems Biology,1 Cancer Biology Program, Department of Medicine, Beth Israel Deaconness Medical Center, Harvard Medical School, Boston, Massachusetts,5 Center for Immunology and Department of Molecular Biology and Biochemistry, University of California—Irvine, Irvine, California,4 Institut fuer Biochemie, Freie Universitaet Berlin, Berlin, Germany,2 Department of Experimental Oncology, European Institute of Oncology, Milan, Italy3

Received 14 August 2004/ Returned for modification 4 October 2004/ Accepted 20 December 2004

Class Ia phosphoinositide 3-kinases (PI3Ks) are heterodimers of p110 catalytic and p85 regulatory subunits that mediate a variety of cellular responses to growth and differentiation factors. Although embryonic development is not impaired in mice lacking all isoforms of the p85{alpha} gene (p85{alpha}–/– p55{alpha}–/– p50{alpha}–/–) or in mice lacking the p85ß gene (p85ß–/–) (D. A. Fruman, F. Mauvais-Jarvis, D. A. Pollard, C. M. Yballe, D. Brazil, R. T. Bronson, C. R. Kahn, and L. C. Cantley, Nat Genet. 26:379-382, 2000; K. Ueki, C. M. Yballe, S. M. Brachmann, D. Vicent, J. M. Watt, C. R. Kahn, and L. C. Cantley, Proc. Natl. Acad. Sci. USA 99:419-424, 2002), we show here that loss of both genes results in lethality at embryonic day 12.5 (E12.5). The phenotypes of these embryos, including subepidermal blebs flanking the neural tube at E8 and bleeding into the blebs during the turning process, are similar to defects observed in platelet-derived growth factor receptor {alpha} null (PDGFR{alpha}–/–) mice (P. Soriano, Development 124:2691-2700, 1997), suggesting that PI3K is an essential mediator of PDGFR{alpha} signaling at this developmental stage. p85{alpha}–/– p55{alpha}+/+ p50{alpha}+/+ p85ß–/– mice had similar but less severe defects, indicating that p85{alpha} and p85ß have a critical and redundant function in development. Mouse embryo fibroblasts deficient in all p85{alpha} and p85ß gene products (p85{alpha}–/– p55{alpha}–/– p50{alpha}–/– p85ß–/–) are defective in PDGF-induced membrane ruffling. Overexpression of the Rac-specific GDP-GTP exchange factor Vav2 or reintroduction of p85{alpha} or p85ß rescues the membrane ruffling defect. Surprisingly, reintroduction of p50{alpha} also restored PDGF-dependent membrane ruffling. These results indicate that class Ia PI3K is critical for PDGF-dependent actin rearrangement but that the SH3 domain and the Rho/Rac/Cdc42-interacting domain of p85, which lacks p50{alpha}, are not required for this response.

* Corresponding author. Mailing address: Beth Israel Hospital, NRB, Division of Signal Transduction, 10th Floor, 330 Brookline, MA 02215. Phone: (617) 667-0947. Fax: (617) 667-0957. E-mail: lewis_cantley{at}hms.harvard.edu.

Molecular and Cellular Biology, April 2005, p. 2593-2606, Vol. 25, No. 7
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.7.2593-2606.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Rabinovsky, R., Pochanard, P., McNear, C., Brachmann, S. M., Duke-Cohan, J. S., Garraway, L. A., Sellers, W. R. (2009). p85 Associates with Unphosphorylated PTEN and the PTEN-Associated Complex. Mol. Cell. Biol. 29: 5377-5388 [Abstract] [Full Text]  
  • Alcazar, I., Cortes, I., Zaballos, A., Hernandez, C., Fruman, D. A., Barber, D. F., Carrera, A. C. (2009). p85{beta} phosphoinositide 3-kinase regulates CD28 coreceptor function. Blood 113: 3198-3208 [Abstract] [Full Text]  
  • Gates, A., Hohenester, S., Anwer, M. S., Webster, C. R. L. (2009). cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 {beta}/{alpha} in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G764-G774 [Abstract] [Full Text]  
  • Minhajuddin, M., Bijli, K. M., Fazal, F., Sassano, A., Nakayama, K. I., Hay, N., Platanias, L. C., Rahman, A. (2009). Protein Kinase C-{delta} and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-{kappa}B Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells. J. Biol. Chem. 284: 4052-4061 [Abstract] [Full Text]  
  • Kaur, S., Sassano, A., Joseph, A. M., Majchrzak-Kita, B., Eklund, E. A., Verma, A., Brachmann, S. M., Fish, E. N., Platanias, L. C. (2008). Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling. J. Immunol. 181: 7316-7323 [Abstract] [Full Text]  
  • Horn, M. P., Knecht, S. M., Rushing, F. L., Birdsong, J., Siddall, C. P., Johnson, C. M., Abraham, T. N., Brown, A., Volk, C. B., Gammon, K., Bishop, D. L., McKillip, J. L., McDowell, S. A. (2008). Simvastatin Inhibits Staphylococcus aureus Host Cell Invasion through Modulation of Isoprenoid Intermediates. J. Pharmacol. Exp. Ther. 326: 135-143 [Abstract] [Full Text]  
  • Tsukamoto, K., Hazeki, K., Hoshi, M., Nigorikawa, K., Inoue, N., Sasaki, T., Hazeki, O. (2008). Critical Roles of the p110{beta} Subtype of Phosphoinositide 3-Kinase in Lipopolysaccharide-Induced Akt Activation and Negative Regulation of Nitrite Production in RAW 264.7 Cells. J. Immunol. 180: 2054-2061 [Abstract] [Full Text]  
  • Pickett, E. A., Olsen, G. S., Tallquist, M. D. (2008). Disruption of PDGFR{alpha}-initiated PI3K activation and migration of somite derivatives leads to spina bifida. Development 135: 589-598 [Abstract] [Full Text]  
  • Senft, J., Helfer, B., Frisch, S. M. (2007). Caspase-8 Interacts with the p85 Subunit of Phosphatidylinositol 3-Kinase to Regulate Cell Adhesion and Motility. Cancer Res. 67: 11505-11509 [Abstract] [Full Text]  
  • Jossin, Y., Goffinet, A. M. (2007). Reelin Signals through Phosphatidylinositol 3-Kinase and Akt To Control Cortical Development and through mTor To Regulate Dendritic Growth. Mol. Cell. Biol. 27: 7113-7124 [Abstract] [Full Text]  
  • Bosse, T., Ehinger, J., Czuchra, A., Benesch, S., Steffen, A., Wu, X., Schloen, K., Niemann, H. H., Scita, G., Stradal, T. E. B., Brakebusch, C., Rottner, K. (2007). Cdc42 and Phosphoinositide 3-Kinase Drive Rac-Mediated Actin Polymerization Downstream of c-Met in Distinct and Common Pathways. Mol. Cell. Biol. 27: 6615-6628 [Abstract] [Full Text]  
  • Magalhaes, M. A. O., Zhu, F., Sarantis, H., Gray-Owen, S. D., Ellen, R. P., Glogauer, M. (2007). Expression and translocation of fluorescent-tagged p21-activated kinase-binding domain and PH domain of protein kinase B during murine neutrophil chemotaxis. J. Leukoc. Biol. 82: 559-566 [Abstract] [Full Text]  
  • Matheu, M. P., Deane, J. A., Parker, I., Fruman, D. A., Cahalan, M. D. (2007). Class IA Phosphoinositide 3-Kinase Modulates Basal Lymphocyte Motility in the Lymph Node. J. Immunol. 179: 2261-2269 [Abstract] [Full Text]  
  • Walker, V. G., Ammer, A., Cao, Z., Clump, A. C., Jiang, B.-H., Kelley, L. C., Weed, S. A., Zot, H., Flynn, D. C. (2007). PI3K activation is required for PMA-directed activation of cSrc by AFAP-110. Am. J. Physiol. Cell Physiol. 293: C119-C132 [Abstract] [Full Text]  
  • Bone, H. K., Welham, M. J. (2007). Phosphoinositide 3-kinase signalling regulates early development and developmental haemopoiesis. J. Cell Sci. 120: 1752-1762 [Abstract] [Full Text]  
  • Taniguchi, C. M., Aleman, J. O., Ueki, K., Luo, J., Asano, T., Kaneto, H., Stephanopoulos, G., Cantley, L. C., Kahn, C. R. (2007). The p85{alpha} Regulatory Subunit of Phosphoinositide 3-Kinase Potentiates c-Jun N-Terminal Kinase-Mediated Insulin Resistance. Mol. Cell. Biol. 27: 2830-2840 [Abstract] [Full Text]  
  • Deane, J. A., Kharas, M. G., Oak, J. S., Stiles, L. N., Luo, J., Moore, T. I., Ji, H., Rommel, C., Cantley, L. C., Lane, T. E., Fruman, D. A. (2007). T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling. Blood 109: 2894-2902 [Abstract] [Full Text]  
  • Dalmizrak, O., Wu, A., Chen, J., Sun, H., Utama, F. E., Zambelli, D., Tran, T. H., Rui, H., Baserga, R. (2007). Insulin Receptor Substrate-1 Regulates the Transformed Phenotype of BT-20 Human Mammary Cancer Cells. Cancer Res. 67: 2124-2130 [Abstract] [Full Text]  
  • Lee, J. H., Ragolia, L. (2006). AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 291: C1355-C1365 [Abstract] [Full Text]  
  • Oak, J. S., Deane, J. A., Kharas, M. G., Luo, J., Lane, T. E., Cantley, L. C., Fruman, D. A. (2006). Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc. Natl. Acad. Sci. USA 103: 16882-16887 [Abstract] [Full Text]  
  • Katso, R. M., Pardo, O. E., Palamidessi, A., Franz, C. M., Marinov, M., De Laurentiis, A., Downward, J., Scita, G., Ridley, A. J., Waterfield, M. D., Arcaro, A. (2006). Phosphoinositide 3-Kinase C2beta Regulates Cytoskeletal Organization and Cell Migration via Rac-dependent Mechanisms. Mol. Biol. Cell 17: 3729-3744 [Abstract] [Full Text]  
  • Hazeki, K., Kinoshita, S., Matsumura, T., Nigorikawa, K., Kubo, H., Hazeki, O. (2006). Opposite Effects of Wortmannin and 2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one Hydrochloride on Toll-Like Receptor-Mediated Nitric Oxide Production: Negative Regulation of Nuclear Factor-{kappa}B by Phosphoinositide 3-Kinase. Mol. Pharmacol. 69: 1717-1724 [Abstract] [Full Text]  
  • Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., Cantley, L. C. (2005). Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy. Mol. Cell. Biol. 25: 9491-9502 [Abstract] [Full Text]  
  • Luo, J., Field, S. J., Lee, J. Y., Engelman, J. A., Cantley, L. C. (2005). The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. JCB 170: 455-464 [Abstract] [Full Text]  
  • Luo, J., Sobkiw, C. L., Logsdon, N. M., Watt, J. M., Signoretti, S., O'Connell, F., Shin, E., Shim, Y., Pao, L., Neel, B. G., DePinho, R. A., Loda, M., Cantley, L. C. (2005). Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 102: 10238-10243 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»